» Articles » PMID: 39153979

Epidemiology, Ventilation Management and Outcomes of COVID-19 ARDS Patients Versus Patients with ARDS Due to Pneumonia in the Pre-COVID Era

Abstract

Background: Ventilation management may differ between COVID-19 ARDS (COVID-ARDS) patients and patients with pre-COVID ARDS (CLASSIC-ARDS); it is uncertain whether associations of ventilation management with outcomes for CLASSIC-ARDS also exist in COVID-ARDS.

Methods: Individual patient data analysis of COVID-ARDS and CLASSIC-ARDS patients in six observational studies of ventilation, four in the COVID-19 pandemic and two pre-pandemic. Descriptive statistics were used to compare epidemiology and ventilation characteristics. The primary endpoint were key ventilation parameters; other outcomes included mortality and ventilator-free days and alive (VFD-60) at day 60.

Results: This analysis included 6702 COVID-ARDS patients and 1415 CLASSIC-ARDS patients. COVID-ARDS patients received lower median V (6.6 [6.0 to 7.4] vs 7.3 [6.4 to 8.5] ml/kg PBW; p < 0.001) and higher median PEEP (12.0 [10.0 to 14.0] vs 8.0 [6.0 to 10.0] cm HO; p < 0.001), at lower median ΔP (13.0 [10.0 to 15.0] vs 16.0 [IQR 12.0 to 20.0] cm HO; p < 0.001) and higher median Crs (33.5 [26.6 to 42.1] vs 28.1 [21.6 to 38.4] mL/cm HO; p < 0.001). Following multivariable adjustment, higher ΔP had an independent association with higher 60-day mortality and less VFD-60 in both groups. Higher PEEP had an association with less VFD-60, but only in COVID-ARDS patients.

Conclusions: Our findings show important differences in key ventilation parameters and associations thereof with outcomes between COVID-ARDS and CLASSIC-ARDS.

Trial Registration: Clinicaltrials.gov (identifier NCT05650957), December 14, 2022.

Citing Articles

A Review on Risk Factors, Traditional Diagnostic Techniques, and Biomarkers for Pneumonia Prognostication and Management in Diabetic Patients.

Anwar S, Alhumaydhi F, Rahmani A, Kumar V, Alrumaihi F Diseases. 2024; 12(12.

PMID: 39727640 PMC: 11726889. DOI: 10.3390/diseases12120310.


An Overview of Pediatric Pulmonary Complications During COVID-19 Pandemic: A Lesson for Future.

Roshanzamir Z, Mohammadi F, Yadegar A, Naeini A, Hojabri K, Shirzadi R Immun Inflamm Dis. 2024; 12(11):e70049.

PMID: 39508631 PMC: 11542302. DOI: 10.1002/iid3.70049.

References
1.
Zampieri F, Costa E, Iwashyna T, Carvalho C, Damiani L, Taniguchi L . Heterogeneous effects of alveolar recruitment in acute respiratory distress syndrome: a machine learning reanalysis of the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial. Br J Anaesth. 2019; 123(1):88-95. DOI: 10.1016/j.bja.2019.02.026. View

2.
Schuijt M, Hol L, Nijbroek S, Ahuja S, van Meenen D, Mazzinari G . Associations of dynamic driving pressure and mechanical power with postoperative pulmonary complications-posthoc analysis of two randomised clinical trials in open abdominal surgery. EClinicalMedicine. 2022; 47:101397. PMC: 9035701. DOI: 10.1016/j.eclinm.2022.101397. View

3.
van Meenen D, Algera A, Schuijt M, Simonis F, van der Hoeven S, Serpa Neto A . Effect of mechanical power on mortality in invasively ventilated ICU patients without the acute respiratory distress syndrome: An analysis of three randomised clinical trials. Eur J Anaesthesiol. 2022; 40(1):21-28. DOI: 10.1097/EJA.0000000000001778. View

4.
Gattinoni L, Tonetti T, Cressoni M, Cadringher P, Herrmann P, Moerer O . Ventilator-related causes of lung injury: the mechanical power. Intensive Care Med. 2016; 42(10):1567-1575. DOI: 10.1007/s00134-016-4505-2. View

5.
Brown-Brumfield D, DeLeon A . Adherence to a medication safety protocol: current practice for labeling medications and solutions on the sterile field. AORN J. 2010; 91(5):610-7. DOI: 10.1016/j.aorn.2010.03.002. View